Private equity firms among Elevation Oncology largest holders saw gain after stock jumped 34% last week

 

• Elevation Oncology's significant private equity firms ownership suggests that the key decisions are influenced by shareholders from the larger public

• The top 6 shareholders own 56% of the company

• Institutions own 14% of Elevation Oncology

Every investor in Elevation Oncology, Inc. (NASDAQ:ELEV) should be aware of the most powerful shareholder groups. And the group that holds the biggest piece of the pie are private equity firms with 39% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

Clearly, private equity firms benefitted the most after the company's market cap rose by US$33m last week.

https://finance.yahoo.com/news/private-equity-firms-among-elevation-105438019.html